Laboratory for Biomaterials and Bioengineering, Department of Mining, Metallurgical and Materials Engineering and University Hospital Research Center, Université Laval, Québec City, QC, Canada.
Acta Biomater. 2010 May;6(5):1843-51. doi: 10.1016/j.actbio.2010.01.008. Epub 2010 Jan 18.
In the search for a metallic material showing moderate and uniform degradation for application as degradable cardiovascular stents, electroformed iron (E-Fe) was evaluated by in vitro degradation and cell viability tests. Static immersion and dynamic degradation were used to evaluate degradation rate and mechanism, while cell viability assay was used to assess cytotoxicity. The results were compared with those of iron fabricated by casting and thermomechanical treatment previously investigated as a stent material. Electroformed iron showed faster degradation than iron fabricated by casting (0.25 vs. 0.14 mm year(-1)), with a uniform degradation mechanism. Cell viability results showed that E-Fe did not result in a decrease in metabolic activity when exposed to primary rat smooth muscle cells. However, it caused a decrease in cell proliferation activity which could be beneficial for the inhibition of in-stent restenosis.
在寻找一种具有适度均匀降解性的金属材料,以应用于可降解心血管支架时,我们通过体外降解和细胞活力测试对电铸铁(E-Fe)进行了评估。静态浸泡和动态降解用于评估降解速率和机制,而细胞活力测定用于评估细胞毒性。结果与先前作为支架材料研究的铸造和热机械处理铁进行了比较。电铸铁的降解速度比铸造铁快(0.25 比 0.14 毫米/年),且具有均匀的降解机制。细胞活力结果表明,暴露于原代大鼠平滑肌细胞时,E-Fe 不会降低细胞代谢活性。然而,它会降低细胞增殖活性,这可能有利于抑制支架内再狭窄。